ISO 9001:2015 Certified WHO-GMP PCD Pharma Franchise Company in India300+ Products Monopoly Rights Pan India DistributionCall us: +91-86533 91199
ISO 9001:2015 Certified WHO-GMP PCD Pharma Franchise Company in India300+ Products Monopoly Rights Pan India DistributionCall us: +91-86533 91199
ARPOD-CV DRY SYP

HEFTYCAL-D

Product Packing: 10X15

Product Composition: Calcium Carbonate 1250 mg + Vit D3 250 I.U.

Product Price: MRP : 940

HEFTYCAL-D Tablets

Calcium Carbonate 1250 mg + Vitamin D3 250 I.U. Tablets

HEFTYCAL-D is a calcium and vitamin D3 formulation containing Calcium Carbonate 1250 mg with Vitamin D3 250 I.U. The combination is intended to provide calcium and vitamin D supplementation where dietary intake or individual requirements make supplementation appropriate.

Calcium is an essential mineral for normal bone and teeth structure, while Vitamin D3 supports intestinal calcium absorption and normal calcium-phosphate balance. Use should follow the approved product label and professional advice.

Composition

Each tablet contains:

·         Calcium Carbonate - 1250 mg

·         Vitamin D3 (Cholecalciferol) - 250 I.U.

·         Excipients - q.s.

Dosage form: Tablet

Pack size: 15 x 10 tablets

Uses of HEFTYCAL-D

HEFTYCAL-D may be used as a calcium and vitamin D supplement in selected individuals where supplementation is considered appropriate.

·         Prevention and correction of inadequate calcium and vitamin D intake

·         Nutritional support for maintenance of normal bones and teeth

·         Support during periods of increased calcium requirement when advised by a healthcare professional

·         Adjunctive nutritional support in bone-health management where calcium and vitamin D supplementation is appropriate

The product should be used according to the approved label. Persistent bone pain, muscle weakness or suspected deficiency requires appropriate medical evaluation.

How HEFTYCAL-D Works

HEFTYCAL-D combines Calcium Carbonate with Vitamin D3:

Calcium Carbonate: Provides elemental calcium required for normal bone mineralization, teeth, muscle contraction and other physiological functions.

Vitamin D3: Helps regulate calcium and phosphate metabolism and supports intestinal absorption and utilization of calcium.

Combined support: Adequate calcium together with vitamin D contributes to maintenance of normal bone structure and mineral balance.

Individual calcium and vitamin D requirements vary according to diet, age, medical status and other factors.

Use supplementation at the dose and duration recommended on the approved label or by a qualified healthcare professional.

 

Dosage and Direction for Use

Use HEFTYCAL-D according to the approved product label or as directed by a qualified healthcare professional. Dose and duration depend on individual requirements, dietary intake and clinical circumstances.

Swallow the tablet with water unless otherwise directed.

Calcium Carbonate is commonly taken with food for better absorption unless the approved label or prescriber advises otherwise.

Do not exceed the recommended dose or combine with other calcium or vitamin D products without professional advice.

Possible Side Effects

Calcium and vitamin D supplements are generally well tolerated at appropriate doses, but unwanted effects may occur. Possible effects can include:

·         Constipation, gas, bloating or abdominal discomfort

·         Nausea or other mild gastrointestinal disturbance

·         Excessive intake may contribute to elevated calcium levels in susceptible individuals

·         Allergic or hypersensitivity reactions to formulation ingredients are possible

·         Symptoms such as persistent vomiting, unusual weakness, excessive thirst or increased urination require medical advice, particularly if excessive calcium or vitamin D intake is suspected.

Seek prompt professional advice for severe or unusual reactions.

Precautions and Contraindications

Before using HEFTYCAL-D, relevant medical history, calcium status, kidney function and concomitant medicines or supplements should be considered. Important precautions include:

·         Do not use in patients with known hypersensitivity to any ingredient or formulation component.

·         Use only under professional guidance in patients with hypercalcaemia, hypercalciuria or conditions predisposing to elevated calcium levels.

·         Use caution in kidney disease, kidney stones or significant renal impairment.

·         Patients already taking calcium, vitamin D or multivitamin supplements should have total intake reviewed to avoid unnecessary duplication.

·         Pregnancy and breastfeeding: supplementation should follow professional assessment of dietary and individual requirements.

·         Children, older adults and patients with chronic medical conditions should use the product under appropriate professional guidance.

·         Keep out of reach of children and store according to pack instructions, protected from excessive heat, light and moisture.

·         Drug Interaction Considerations

·         Calcium can reduce the absorption of certain medicines, including some antibiotics, thyroid medicines and other drugs, when taken at the same time. Dose separation may be required. Vitamin D may also require caution with certain medicines affecting calcium metabolism.

·         Patients taking regular medicines should consult a healthcare professional regarding suitable timing and possible interactions.

Business Growth Opportunity with HEFTYCAL-D

HEFTYCAL-D offers pharmaceutical distributors and healthcare entrepreneurs an opportunity to add a Calcium Carbonate and Vitamin D3 tablet to their bone-health and nutritional portfolio.

Calcium and vitamin D supplementation represents an established healthcare segment. Responsible promotion of HEFTYCAL-D should remain consistent with approved product information and applicable regulations.

 

Key Business Advantages

·         Calcium Carbonate with Vitamin D3 formulation

·         Calcium Carbonate 1250 mg + Vitamin D3 250 I.U.

·         Convenient tablet dosage form

·         Suitable addition to calcium, bone-health and nutritional portfolios

·         Potential for ethical promotion through appropriate healthcare channels

·         Opportunity for territory-based pharmaceutical distribution

PCD Pharma Franchise Opportunity for HEFTYCAL-D

Ethics Medinova Private Limited offers PCD Pharma Franchise opportunities for HEFTYCAL-D in selected territories across India, subject to availability, applicable regulations and mutually agreed business terms.

Franchise partners may benefit from the company’s product portfolio, promotional support, supply coordination and business assistance.

 

Franchise Support May Include

·         Monopoly-based territory opportunities, subject to availability

·         Promotional materials and visual aids

·         Product information and marketing support

·         Reliable supply coordination

·         Access to a growing pharmaceutical product portfolio

·         Professional partner assistance

Partner with Ethics Medinova to explore PCD Pharma Franchise opportunities for HEFTYCAL-D and other quality-focused healthcare products.

Third-Party Manufacturing Support for Calcium Carbonate & Vitamin D3 Tablets

Ethics Medinova also supports businesses exploring third-party manufacturing of Calcium Carbonate and Vitamin D3 Tablets under their own brand, subject to applicable licensing, regulatory and manufacturing requirements.

Our third-party manufacturing support may include:

·         Customized product and pack requirements, subject to regulatory feasibility

·         Private-label manufacturing opportunities

·         Customized packaging and branding support

·         Product label and pack configuration assistance

·         Manufacturing coordination through suitable licensed facilities

·         Support for documentation and applicable regulatory requirements

This service may be suitable for pharmaceutical companies, healthcare brands, startups and entrepreneurs seeking to expand a calcium, bone-health or nutritional product portfolio.

Frequently Asked Questions About HEFTYCAL-D

1. What is HEFTYCAL-D?

HEFTYCAL-D is a tablet formulation containing Calcium Carbonate 1250 mg and Vitamin D3 250 I.U.

2. What is HEFTYCAL-D used for?

It may be used as a calcium and vitamin D supplement where additional intake is considered appropriate for nutritional and bone-health support.

3. How should HEFTYCAL-D be taken?

Take HEFTYCAL-D according to the approved product label or as directed by a qualified healthcare professional. Do not exceed the recommended dose.

4. Can HEFTYCAL-D be used for a long period?

Duration of supplementation should follow the approved label and professional advice, taking into account diet, calcium and vitamin D intake, medical conditions and individual requirements.

5. Can HEFTYCAL-D interact with other medicines?

Yes. Calcium may reduce absorption of certain medicines when taken together, so dose separation may be necessary. Patients should provide their complete medicine and supplement list to a healthcare professional.

6. Who should seek medical advice before using this product?

People with kidney disease or kidney stones, high calcium levels, chronic medical conditions, pregnancy or breastfeeding, or those taking regular medicines or other calcium/vitamin D supplements should obtain professional advice.

7. Is a PCD Pharma Franchise available for HEFTYCAL-D?

Yes. Ethics Medinova offers PCD Pharma Franchise opportunities for selected products and territories, subject to availability and mutually agreed terms.

8. Can this formulation be manufactured under my own brand?

Businesses interested in Calcium Carbonate and Vitamin D3 Tablets may explore third-party manufacturing and private-label support with Ethics Medinova, subject to applicable regulatory requirements.

Disclaimer

HEFTYCAL-D product information in this document is for general and professional business information. Exact ingredient specifications, elemental calcium equivalence, indications, dosage, contraindications, warnings, interactions, excipients and regulatory status should be verified against the current approved product label before use or promotion. This document is not a substitute for professional medical advice.

Contact